{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:16Z","timestamp":1740115036594,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV000640_2018"],"award-info":[{"award-number":["INV000640_2018"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.05.057","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:33:37Z","timestamp":1716953617000},"page":"126009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longevity of serologic responses following a single dose of typhoid conjugate vaccine among children living with HIV in Pakistan: A prospective cohort study"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-5874","authenticated-orcid":false,"given":"Rabab","family":"Batool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Tahir","family":"Yousafzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saqib Ali","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sikander","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah Naz","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2024.05.057_b0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/QCO.0000000000000479","article-title":"Typhoid and paratyphoid fever: a call to action","volume":"31","author":"Gibani","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.057_b0010","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/typhoid."},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.057_b0015","doi-asserted-by":"crossref","first-page":"e27268","DOI":"10.2196\/27268","article-title":"Morbidity and mortality associated with typhoid fever among hospitalized patients in Hyderabad district, Pakistan, 2017\u20132018: retrospective record review","volume":"7","author":"Fatima","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2024.05.057_b0020","unstructured":"https:\/\/www.emro.who.int\/pak\/pakistan-news\/pakistan-first-country-to-introduce-new-typhoid-vaccine-into-routine-immunization-programme.html."},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.057_b0025","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4269\/ajtmh.21-1323","article-title":"Risk factors associated with extensively drug-resistant typhoid in an outbreak setting of Lyari Town Karachi, Pakistan","volume":"106","author":"Batool","year":"2022","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.057_b0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018\u2013Recommendations","volume":"37","author":"Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.057_b0035","doi-asserted-by":"crossref","unstructured":"Nampota-Nkomba N, Carey ME, Jamka LP, Fecteau N, Neuzil KM. Using typhoid conjugate vaccines to prevent disease, promote health equity, and counter drug-resistant typhoid fever. Open Forum Infectious Diseases; 2023: Oxford University Press US; 2023. p. S6-S12.","DOI":"10.1093\/ofid\/ofad022"},{"issue":"06","key":"10.1016\/j.vaccine.2024.05.057_b0040","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"Organization","year":"2008","journal-title":"Wkly Epidemiol Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2024.05.057_b0045","doi-asserted-by":"crossref","unstructured":"Chen J, Long JE, Vannice K, et al. Taking on typhoid: Eliminating typhoid fever as a global health problem. Open Forum infectious diseases; 2023: Oxford University Press US; 2023. p. S74-S81.","DOI":"10.1093\/ofid\/ofad055"},{"issue":"7","key":"10.1016\/j.vaccine.2024.05.057_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7207a2","article-title":"Typhoid fever surveillance, incidence estimates, and progress toward typhoid conjugate vaccine introduction\u2014worldwide, 2018\u20132022","volume":"72","author":"Hancuh","year":"2023","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.05.057_b0055","unstructured":"UNAIDS. Fact sheet: World AIDS Day. UNAIDS New York, NY; 2020."},{"issue":"17","key":"10.1016\/j.vaccine.2024.05.057_b0060","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.3390\/ijms23179797","article-title":"How can we improve the vaccination response in older people? Part II: Targeting immunosenescence of adaptive immunity cells","volume":"23","author":"Garnica","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2024.05.057_b0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"58","author":"Kern\u00e9is","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.057_b0070","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1097\/INF.0000000000000630","article-title":"Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil","volume":"34","author":"Frota","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.057_b0075","doi-asserted-by":"crossref","first-page":"e81715","DOI":"10.1371\/journal.pone.0081715","article-title":"High HIV incidence among persons who inject drugs in Pakistan: greater risk with needle sharing and injecting frequently among the homeless","volume":"8","author":"Samo","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.057_b0080","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3201\/eid2704.204205","article-title":"Systematic review of reported HIV outbreaks, Pakistan, 2000\u20132019","volume":"27","author":"Rabold","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.057_b0085","doi-asserted-by":"crossref","first-page":"e036723","DOI":"10.1136\/bmjopen-2019-036723","article-title":"Investigation of an extensive outbreak of HIV infection among children in Sindh, Pakistan: protocol for a matched case\u2013control study","volume":"10","author":"Siddiqui","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.vaccine.2024.05.057_b0090","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/S2352-3018(19)30179-1","article-title":"HIV outbreaks in Pakistan","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.057_b0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(19)30743-1","article-title":"HIV infection predominantly affecting children in Sindh, Pakistan, 2019: a cross-sectional study of an outbreak","volume":"20","author":"Mir","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.057_b0100","unstructured":"Consolidated guidelines for the prevention and treatment of HIV and AIDS in Pakistan 20Technical guidelines - national AIDS control programme. [cited 2022 Mar28]."},{"issue":"6","key":"10.1016\/j.vaccine.2024.05.057_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jama.1989.03430060075029","article-title":"The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine","volume":"262","author":"Miotti","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.057_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cid\/ciq019","article-title":"Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults","volume":"52","author":"Crum-Cianflone","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.057_b0115","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/QAI.0b013e318232b50e","article-title":"Antibody response to inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with and without HIV","volume":"58","author":"Tiu","year":"2011","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"14","key":"10.1016\/j.vaccine.2024.05.057_b0120","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/QAD.0b013e32833c6d5c","article-title":"Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals","volume":"24","author":"Tebas","year":"2010","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.057_b0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199404000-00008","article-title":"Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes","volume":"8","author":"Kroon","year":"1994","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.057_b0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7326\/0003-4819-109-5-383","article-title":"The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines","volume":"109","author":"Nelson","year":"1988","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.05.057_b0135","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/infdis\/jiu840","article-title":"HIV infection worsens age-associated defects in antibody responses to influenza vaccine","volume":"211","author":"George","year":"2015","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.057_b0140","doi-asserted-by":"crossref","first-page":"e79816","DOI":"10.1371\/journal.pone.0079816","article-title":"Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation","volume":"8","author":"Parmigiani","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.057_b0145","first-page":"115","article-title":"Research Article (New England Journal of Medicine) A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"28","author":"French","year":"2016","journal-title":"Malawi Med J"},{"key":"10.1016\/j.vaccine.2024.05.057_b0150","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S2214-109X(23)00606-X","article-title":"Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis","volume":"12","author":"Batool","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.057_b0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/653112","article-title":"Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial","volume":"51","author":"S\u00f8gaard","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400625X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400625X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:09:00Z","timestamp":1737583740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2400625X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X2400625X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longevity of serologic responses following a single dose of typhoid conjugate vaccine among children living with HIV in Pakistan: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126009"}}